Edesa Biotech, Inc. (NASDAQ:EDSA) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 13, 2026.
The Healthcare company reported Q0 revenue of .
Edesa Biotech, Inc.'s stock currently trades at $1.02 with a market capitalization of $12.3M.